Characteristics of the Functional State of the Musculoskeletal System, Body Awareness, and Quality of Life in Individuals With Joint Hypermobility, Their Associations, and Guidelines for Intervention.
1 other identifier
observational
511
1 country
1
Brief Summary
The goal of this observational study is to learn about the characteristics of the functional state of the musculoskeletal system, body awareness, and quality of life in individuals with joint hypermobility, their associations, and guidelines for intervention.The main questions it aims to answer are:
- 1.To evaluate the joint hypermobility in young women and the associated symptoms using translated, adapted, and validated Lithuanian versions of questionnaires;
- 2.To evaluate and compare the functional characteristics of the musculoskeletal system in women with and without generalized joint hypermobility;
- 3.To evaluate and compare the characteristics of the objective and subjective body awareness and quality of life of women with and without general joint hypermobility;
- 4.To determine the characteristics and correlations of the functional state of the musculoskeletal system, body awareness and quality of life in subjects with general joint hypermobility;
- 5.To develop guidelines for the management of individuals with generalized joint hypermobility within the scope of competence of a physical therapist.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 9, 2026
CompletedFirst Posted
Study publicly available on registry
March 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2029
March 17, 2026
March 1, 2026
3 years
March 9, 2026
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Questionnaire survey
Several short surveys will be conducted. One of them will be accessible via a QR code and an active link, which will be added to the invitation to participate in the study. This short survey is designed to help us immediately select participants based on inclusion and exclusion criteria. Participants will complete this survey online and will be able to see whether they are eligible for the study. The second survey will be conducted at the Department of Sports Medicine, and participants will complete it in paper form. This questionnaire will seek to identify the health characteristics of the subjects that are important for safe testing. The third questionnaire will be designed to identify certain lifestyle factors and characteristics of pain experienced that may be related to joint hypermobility.
The survey will take up to 5 minutes to complete.
Five part questionnaire
Takes up to 2 minutes
Beighton score
Takes up to 5 minutes
Baecke Physical Activity questionnaire
Takes up to 5 minutes
Bristol Impact of Hypermobility questionnaire
Takes up to 10 minutes
SF-36 questionnaire
This questionnaire will be used in the cultural adaptation process of the Bristol Impact of Hypermobility questionnaire.
Takes up to 5 minutes
Secondary Outcomes (9)
Numerical Rating Scale
will take up to 2 minutes
Body map
will take up to 2 minutes
Height and weight measurement
Height and weight assessment takes up to 2 minutes.
Body posture assessment
will take up to 10 minutes
Foot pressure distribution and gait
will take up to 5 minutes
- +4 more secondary outcomes
Study Arms (2)
Generalized joint hypermobility group
Generalized joint hypermobility group
Control group
Without generalized joint hypermobility
Interventions
Eligibility Criteria
First stage of the study (cultural adaptation of the five-part questionnaire and the Bristol Impact of Hypermobility Questionnaire): women and men aged 20 and over who voluntarily agreed to participate in the study. Second stage of the study: women aged 20 to 40 who voluntarily agree to participate in the study. Depending on their Beighton score and Five-Part Questionnaire score, the subjects will be divided into a study group (women with joint hypermobility: 5 or more points on the Beighton scale; 2 or more points on the Five-Part Questionnaire) and a control group (women without joint hypermobility: less than 5 points on the Beighton scale; less than 2 points on the Five-Part Questionnaire).
You may qualify if:
- First stage of the study (cultural adaptation of the five-part questionnaire and the Bristol Impact of Hypermobility Questionnaire): women and men aged 20 and over who voluntarily agreed to participate in the study.
- Second stage of the study: women aged 20 to 40 who voluntarily agree to participate in the study. Depending on their Beighton score and Five-Part Questionnaire score, the subjects will be divided into a study group (women with joint hypermobility: 5 or more points on the Beighton scale; 2 or more points on the Five-Part Questionnaire) and a control group (women without joint hypermobility: less than 5 points on the Beighton scale; less than 2 points on the Five-Part Questionnaire).
You may not qualify if:
- Pregnancy and the first year after childbirth; Connective tissue diseases (e.g., Marfan syndrome, osteogenesis imperfecta); Demyelinating, inflammatory neurological diseases; Malignant tumors; Female athletes; Individuals who participate or have participated in physical activities that emphasize flexibility training; Other systemic diseases (e.g., rheumatoid arthritis, diabetes mellitus); Obesity (BMI \>30 kg/m²); Menopause.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
LSMU Department of Sports Medicine
Kaunas, Lithuania
Related Publications (13)
Engelbert RH, Rombaut L. Clinimetrics: Assessment of generalised joint hypermobility: the Beighton score. J Physiother. 2022;68(3):208. http://doi.org/10.1016/j.jphys.2022.02.004
BACKGROUNDMalfait F, Colman M, Vroman R, De Wandele I, Rombaut L, Miller RE, et al. Pain in the Ehlers-Danlos syndromes: Mechanisms, models, and challenges. Am J Med Genet C Semin Med Genet. 2021;187(4):429-45. http://doi.org/10.1002/ajmg.c.31950
BACKGROUNDHirsch C, Hirsch M, John MT, Bock JJ: Reliability of the Beighton Hypermobility Index to determinate the general joint laxity performed by dentists. J Orofac Orthop 2007; 68: 342-52.
BACKGROUNDBoyle KL, Witt P, Riegger-Krugh C: Intrarater and Interrater Reliability of the Beighton and Horan Joint Mobility Index. J Athl Train 2003; 38: 281-5.
BACKGROUNDEvans AM, Rome K, Peet L: The foot posture index, ankle lunge test, Beighton scale and the lower assessment score in healthy children: a reliability study. J Foot Ankle Res 2012; 5: 1-5.
BACKGROUNDBulbena A, Duro JC, Porta M, Faus S, Vallescar R, Martin-Santos R: Clinical assessment of hypermobility of joints: assembling criteria. J Rheumatol 1992; 19: 115-22.
BACKGROUNDSmits-Engelsman B, Klerks M, Kirby A: Beighton score: a valid measure for generalized hypermobility in children. J Pediatr 2011; 158: 119-23
BACKGROUNDJull-Kristensen B, Rogind H, Jensen DV, Remvig L: Inter-examiner reproducibility of tests and criteria for generalized joint hypermobility and benign joint hypermobility syndrome. Rheumatology (Oxford) 2007; 46: 1835-41.
BACKGROUNDDrevin J, Stern J, Annerbäck EM, Peterson M, Butler S, Tydén T, Berglund A, Larsson M, Kristiansson P. Adverse childhood experiences influence development of pain during pregnancy. Acta Obstet Gynecol Scand. 2015 Aug;94(8):840-6. doi: 10.1111/aogs.12674. Epub 2015 Jun 3. PMID: 25965273; PMCID: PMC5032994.
BACKGROUNDBuderer NMF. Statistical methodology: I. incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med. 1996;3:895-900.
BACKGROUNDGlans M, Humble MB, Elwin M, Bejerot S. Self-rated joint hypermobility: the five-part questionnaire evaluated in a Swedish non-clinical adult population. BMC Musculoskelet Disord. 2020;21(1):174. Published 2020 Mar 17. doi:10.1186/s12891-020-3067-
BACKGROUNDMapi. Linguistic Validation Guidance of a Clinical Outcome Assessment (COA). Linguistic Validation Guidance of a Clinical Outcome Assessment. 2016;33: 1-10.
BACKGROUNDWild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation. Value in Health. 2005;8: 94-104. doi: 10.1111/j.1524-4733.2005.04054.x
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of Sports Medicine
Study Record Dates
First Submitted
March 9, 2026
First Posted
March 17, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
February 1, 2029
Study Completion (Estimated)
February 1, 2029
Last Updated
March 17, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared in order to protect participant privacy and confidentiality.